Literature DB >> 15905915

[Can court injunctions guarantee access to medicines in the public sector? The experience in the State of Rio de Janeiro, Brazil].

Ana Márcia Messeder1, Claudia Garcia Serpa Osorio-de-Castro, Vera Lucia Luiza.   

Abstract

There are increasing numbers of legal suits concerning access to medicines brought against the Rio de Janeiro State Health Department. The situation indicated the need for a study to clarify the underlying issues. A sample of 389 court suits from January 1991 to December 2001 (stratified by year) was used. A cross-sectional design was used to describe and analyze the legal suits in relation to the responsibilities defined under the Unified National Health System (SUS). Results suggest major delays in court decisions. Most suits are filed by the Public Defender's Office for users of the National Health System. The most frequent cases involve medicines for the cardiovascular and nervous systems, many of which involve continuous use. Prescribing practices are institutionalized through the inclusion of the most frequently prescribed drugs in public financing lists, which makes rational drug use difficult to achieve. Municipalities are not fulfilling their responsibility to supply medicines to users, and the State is thus encumbered with these responsibilities. However, the State does not adequately supply medicines to the municipalities. The apparent lack of awareness among both lawyers and clients generates stress between the Executive and Judiciary branches and limits the resources for collective pharmaceutical services.

Mesh:

Year:  2005        PMID: 15905915     DOI: 10.1590/s0102-311x2005000200019

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  7 in total

1.  Strategies Implemented by Public Institutions to Approach the Judicialization of Health Care in Brazil: A Systematic Scoping Review.

Authors:  Sueli Miyuki Yamauti; Jorge Otavio Maia Barreto; Silvio Barberato-Filho; Luciane Cruz Lopes
Journal:  Front Pharmacol       Date:  2020-07-30       Impact factor: 5.810

2.  Characterization of the selection of medicines for the Brazilian primary health care.

Authors:  Margô Gomes de Oliveira Karnikowski; Dayani Galato; Micheline Marie Milward de Azevedo Meiners; Emília Vitória da Silva; Letícia Farias Gerlack; Ângelo José Gonçalves Bós; Silvana Nair Leite; Juliana Álvares; Ione Aquemi Guibu; Orlando Mario Soeiro; Karen Sarmento Costa; Ediná Alves Costa; Augusto Afonso Guerra; Francisco de Assis Acurcio
Journal:  Rev Saude Publica       Date:  2017-11-13       Impact factor: 2.106

3.  Antiretroviral drug expenditure, pricing and judicial demand: an analysis of federal procurement data in Brazil from 2004-2011.

Authors:  Jing Luo; Maria A Oliveira; Mariana B C Ramos; Aurélio Maia; Claudia G S Osorio-de-Castro
Journal:  BMC Public Health       Date:  2014-04-16       Impact factor: 3.295

4.  The Judicialization of Health and the Quest for State Accountability: Evidence from 1,262 Lawsuits for Access to Medicines in Southern Brazil.

Authors:  João Biehl; Mariana P Socal; Joseph J Amon
Journal:  Health Hum Rights       Date:  2016-06

Review 5.  Prioritization of strategies to approach the judicialization of health in Latin America and the Caribbean.

Authors:  Carlos Eduardo Pinzón-Flórez; Evelina Chapman; Leonardo Cubillos; Ludovic Reveiz
Journal:  Rev Saude Publica       Date:  2016-09-01       Impact factor: 2.106

6.  Difficulties in the diagnosis and treatment of rare diseases according to the perceptions of patients, relatives and health care professionals.

Authors:  Marcos Thomazin Lopes; Vera Hermina Koch; Vicente Sarrubbi-Junior; Paulo Rogério Gallo; Magda Carneiro-Sampaio
Journal:  Clinics (Sao Paulo)       Date:  2018-04-05       Impact factor: 2.365

7.  Individual Health Care Litigation in Brazil through a Different Lens: Strengthening Health Technology Assessment and New Models of Health Care Governance.

Authors:  Danielle da Costa Leite Borges
Journal:  Health Hum Rights       Date:  2018-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.